Add time:07/15/2019         Source:sciencedirect.com

The structure–activity relationships (SARs) of acylthiocarbamates (ATCs), a new class of non-nucleoside HIV-1 reverse transcriptase inhibitors, have been expanded. Sixty-six new analogues were prepared by parallel solution-phase synthesis. In general, the potency of new ATCs was better than that of the first series and O-[2-phthalimidoethyl] 4-chlorophenyl(3-nitrobenzoyl) thiocarbamate turned out to be the most potent ATC so far synthesized (EC50 = 1.5 nM). Several ATCs were active at micromolar concentrations against HIV-1 strains carrying the RT Y181C mutation and one of them was also moderately active against the K103R variant. Docking simulations were carried out to rationalize the most relevant SARs.

We also recommend Trading Suppliers and Manufacturers of 1-({3-chloro-6-nitro-1-benzothien-2-yl}carbonyl)-3-methylpiperidine (cas 351981-95-8). Pls Click Website Link as below: cas 351981-95-8 suppliers